Interferon-gamma (IFN-γ)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 113-122

  Kawakami, Kazuyoshi ^a   Qureshi, M H ^a   Zhang, T ^a   Koguchi, Y ^a   Shibuya, K ^b   Naoe, S ^b   Saito, A ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Chemokines; Cryptococcus neoformans; IL 12; Interferon gamma; Lungs

Indexed keywords

CHEMOATTRACTANT; GAMMA INTERFERON; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; INFECTION RESISTANCE; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CHEMOKINE CCL2; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; LUNG; LUNG DISEASES, FUNGAL; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; RANTES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033013083     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00955.x     Document Type: Article

References (46)

1. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76.
2. Skeen MS, Ziegler HK. Activation of γδ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J Immunol 1095; 154:5832-41.
3. Dunn PL, North RJ. Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun 1991; 59:2892-900.
4. Laskay T, Rolinghoff M, Solbach W. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur J Immunol 1993; 23:2237-41.
5. Rosal JP, MacDonald HR, Louis JA. A role for γδ+ T cells during experimental infection of mice with Leishmania major. J Immunol 1993; 150:550-5.
6. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178:567-77.
7. Hsieh CS, Macatonia SE, Tripp CS, O'Garra A, Murphy KA. Development of Th1, CD41 T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260:547-9.
8. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
9. Trinchieri G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type I and cytotoxic lymphocytes. Blood 1994; 84:4008-27.
10. Taylor AP, Murray HW, Intracellular antimicrobial activity in the absence of interferon-γ: Effect of interleukin-12 in experimental viseral leishmaniasis in interferon-γ gene-disrupted mice. J Exp Med 1997; 185:1231-9.
11. Zilocchi C, Stoppacciaro A, Chiodoni C, Parenza M, Terrazini N, Colombo MP. Interferon γ-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and granulocyte/macrophage colony-stimulating factor. J Exp Med 1998; 188:133-43.
12. Wang ZE, Zheng S, Corry DR, Dalton DK, Seder RA, Reiner SL, Locksley RM. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA 1994; 91:12932-6.
13. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994; 55:97-179.
14. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991; 9:617-48.
15. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu H, Leonard EJ. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989; 169:1449-59.
16. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelocytic cell line. J Exp Med 1989; 169:1485-90.
17. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994; 91:3652-6.
18. Schall TJ, Bacon K, Toy KJ, Goeddel DV, Selective attraction of monocytes and T lymphocyte of the memory phenotype by the cytokine RANTES. Nature 1990; 347:669-71.
19. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176:587-92.
20. Roi A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176:1489-95.
21. Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, Dahinden CA. RANTES and related chemokines activate human basophilgranulocytes through different G protein-coupled receptors. Eur J Immunol 1993; 23:761-7.
22. Sherry B, Tekamp-Olson P, Gallegos C, Bauer D, Davatelis G, Masiarz F, Coit D, Cerami A. Resolution of the two components of macrophage inflammatory protein 1 and cloning and characterization of one of those components, macrophage inflammatory protein 1β. J Exp Med 1998; 168:2251-9.
23. Schall TJ, Bacon K, Camp RDR, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein-1α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J Exp Med 1993; 177:1821-5.
24. Taub DD, Lloyd AR, Conlon K et al. Recombinant human interferon-γ inducible protein 10 is chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809-14.
25. Kuwakami K, Tohyama M, Xie Q, Saito A. Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996; 104:208-14.
26. Huffnagle GB, Strieter RM, Standiford TS, McDonald RA, Burdick MD, Kunkel SL, Toews GB. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995; 155:4790-7.
27. Huffnagle GB, Strieter RM, McNeil LK, McDonald RA, Burdick MD, Kunkel SL, Toews GB. Macrophage inflammatory protein-1α (MIP-1α is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol 1997; 159:318-27.
28. Doyle HA, Murphy JW. MIP-1 alpha contributes to the anticryptococcal delayed hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol 1997; 61:147-55.
29. Kawakami K, Tohyama M, Xie Q, Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptoccocus neoformans: Effects of interleukin-12. Infect Immun 1997; 65:1307-12.
30. Pearlman E, Lass JHD, Bardenstein S, Diaconu E, Hazlett FE Jr, Albright J, Higgins AW, Kazura JW. IL-12 exacerbates helminth-mediated corneal pathology by augmenting inflammatory cell recruitment and chemokine expression. J Immunol 1997; 158: 827-33.
31. Tessier PA, Naccache PH, Clark-Lewis I, Cladue RP, Neote KS, McColl SR. Chemokine networks in vivo. Involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-α. J Immunol 1997; 159:3595-602.
32. Salkowski CA, Balish E. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcocis. Infect Immun 1991; 59:486-93.
33. Kuwakami K, Tohyama M, Teruya K, Kudeken N, Xie Q, Saito A. Contribution of interferon-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Microbiol 1996; 13:123-30.
34. Granger DL, Hibbs JB Jr, Perfect JR, Durack T. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 1988; 81:1129-36.
35. Tohyama M, Kawakami K, Fulenma M, Saito A. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric, oxide. Clin Exp Immunol 1996; 103:436-41.
36. Levitz SM, North EA, Jiang Y, Nong SH, Kornfeld H, Harrison TS. Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect Immun 1997; 65:903-8.
37. Marfaing-Koka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galamaud P, Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-γ and TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995; 154:1870-8.
38. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D. Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-α, tumor necrosis factor-α, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 1993; 150:1971.
39. Zhou ZHL, Chalurvedi P, Han YL et al. IFN-γ induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: Functional interaction between an TFN-γ-activated site and a GC-rich element. J Immunol 1998; 160:3908-16.
40. Martin CA, Dorf ME. Differential regulation of Interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 1991; 135:245-58.
41. Luster AD, Unkeless JC, Ravetch JV. α-interleukin transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985; 315:672-6.
42. Luster AD, Ravetch JV. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J Exp Med 1987; 166:1084-97.
43. Nathan CN, Kaplan G, Levis, WR et al. Local and systemic effects of low doses of recombinant interferon-γ after intradermal injection in patients with lepromatous leprosy. N Engl J Med 1986; 315:6-15.
44. Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human akin. J Exp Med 1987; 166:1098-108.
45. Narumi S, Wyner LM, Sroler MH, Tannenbaum CS, Hamilton TA. Tissue specific expression of murine IP-10 mRNA following systemic treatment with interferon-γ. J Leukocyte Biol 1992; 52:27-33.
46. Murphy JW. Cryptococcosis. In: Cox RA, ed. Immunology of Fungal Diseases. Boca Raton; CRC Press, 1989:93-138.